德琪医药-B：截至2025年6月30日止六个月中期业绩公告

2025630 20256302024630 63020252024 202463060.87.6202563053.2202312®202320246302025630202422.0 202463027.310.8202563038.1 2024630130.850.9202563079.9 202463056.019.0202563037.0 202463058.519.2202563039.3 2024630167.090.6202563076.4 2024630152.679.7202563072.952.2% ATG-010XPOVIO®®XPO1 •20252®(XVd)(rrMM)202531® •20253(BPOM)®(NDA)(1)(MM)(2)(PI)(IMiD)CD38(mAb)rrMM(3)B(rrDLBCL)B(DLBCL) ATG-022Claudin 18.2 •ATG-022IICLINCH•202512025ATG-022I/IICLINCH2024112221Claudin 18.2 (CLDN18.2)(IHC)2+ ≥ 20%ORR42.9%DCR95.2%1.8 – 2.4 mg/kg10CLDN 18.2IHC 2+ < 20%ORR30.0%DCR50.0%•20255MSD (Merck & Co., Inc., Rahway, NJ, USA)ATG 022MSDPD 1KEYTRUDA® •ATG-037ISTAMINASTAMINAII•202562025ASCOISTAMINA202542743(CPI)286(PR)ORR21.4%16(SD)DCR78.6%11CPI(DCR 100%)ORR36.4%4PR ATG-031CD24 •ATG-031IPERFORM ATG-101PD-L1x4-1BB •A T G - 1 0 1B(B-NHL)IPROBE-CNPROBE OnatasertibATG-008 mTORC1/2 •202562025(ASCO)I/IITORCH-2ATG-008PD-12024112530(QD)15mgATG-00821(Q3W)240 mg14163727(ORR)22.2%(DCR)85.2%PD-L1PD-L1ORR30% (3/10)33.3%(2/6)1.7(1.4,4.2)(DOR)5.795% CI2.7(NE)(PFS)4.295% CI3.3,5.8(OS)21.495% CI15.5NEATG-008(CPI) ATG-042PRMT5-MTAATG-201 (CD19 xCD3 TATG-102LILRB4 x CD3 TATG-106CDH6xCD3 TATG-201GPRC5Dx CD3 TATG-107FLT3x CD3 TATG-110LY6G6Dx CD3 TATG-112ALPPL2 x CD3 T 2+1TAnTenGagerTMT(CRS) AIDeepSeekT(TCE) • • 2017 15®NDA 15 2025 ATG-010XPOVIO®®XPO1 ®(SINE)Karyopharm Therapeutics Inc.Karyopharm® Karyopharm201973(FDA)®PIIMiDCD38 mAbrrMM 2 0 2 062 2®F D ArrDLBCLDLBCL20201218FDA®MM 20217(MFDS)®PIIMiDCD38mAbMMNDAB202112MFDS(sNDA)®MMMFDS202410sNDA 202112( N M P A )®PIIMiDCD38mAbrrMM 20236®(XVd)(PBS)rrMM 20237®NDA( X d )P IIMiDCD38rrMM 20238®®®200100100535® 202312®NDA(Xd)PIIMiDCD38 mAbrrMM 202312®PIIMiDCD38 mAbrrMM202411202411rrDLBCL®2024202511 20246(NHIS)®rrMM202471® 20247NMPA®rrDLBCL 202489®MMNDA 20252®(XVd)rrMM202531® 20253(BPOM)®NDA(1)MM(2)PIIMiDCD38 mAbrrMM(3)rrDLBCLDLBCL 2025630®NDA ®R-GDPrrDLBCLII/IIIKaryopharm(XPORT-DLBCL-030) ATG-022Claudin 18.2202212(HREC)ATG-022 I2023320233NMPA(IND)2023520235ATG-022FDA(ODD)ATG-022 II20255MSDATG 022MSDPD 1KEYTRUDA® ATG-037CD7320222HRECI20226NMPA202211ATG-037 I20237STAMINASTAMINAIb/II ATG-031CD2420235FDAINDB-NHLPERFORM I2023122025630 ATG-101PD-L1x4-1BB20223ATG-101INMPAIND2022820229ATG-101FDAODD ATG-008onatasertib mTORC1/2 ATG-008 (onatasertib)Celgene CorporationonatasertibonatasertibPD-1I/IITORCH-2 202562025( A S C O )I / I ITORCH-2ATG-008PD-12024112530(QD)15 mgATG-00821(Q3W)240mg14163727(ORR)22.2%(DCR)85.2%PD-L1PD-L1ORR30% (3/10)33.3% (2/6)1.7(1.4,4.2)(DOR)5.795% CI2.7 NE(PFS)4.295% CI3.3,5.8(OS)21.495% CI15.5 NEATG-008CPI ATG-008 (ONATASERTIB) ATG-042PRMT5-MTAATG-042IND(CTA) ATG-201CD19 x CD3 TATG-201IND/CTA ATG-106CDH6 x CD3 TATG-106IND/CTA ATG-110LY6G6D x CD3 TATG-110IND/CTA ATG-112ALPPL2 x CD3 TATG-112IND/CTA ATG-102LILRB4 x CD3 TATG-102IND/CTA ATG-021GPRC5D x CD3 TATG-021IND/CTA ATG-107FLT3 x CD3 TATG-107IND/CTA AnTenGagerTM TAnTenGagerT A IDeepSeekTCE 202563099ATG-010XPO1ATG-008onatasertibmTORC1/2ATG-101PD-L1x4-1BBATG-037CD73ATG-022Claudin 18.2ATG-031CD24®2023PIIMiDCD38 mAbrrMM2023202411NMPA20246®rrDLBCL2024202511 2025202463077.5121.720256305(PCT)8PCT 20257NMPA®(XVd)MM 20258ATG-022CLDN18.2HER2(GC/GEJ)NMPA(CDE)(BTD) 2021®ATG-010NDA202220232024DLBCL2025 NDA® 2025630 6–– (76,378)(167,033) (76,378)(167,033) 63020252024 (76,378)(167,033) (11,616)(1,209) (11,616)(1,209) (87,994)(168,242) (87,994)(168,242) 1 2018828MaplesCorporate Services LimitedPO Box 309, Ugland House, Grand Cayman,KY1-1104, Cayman Islands 20201120 2.1 20256303420241231 2.2 20241231 21 21 3 (a) 10% 63020252024 A 4. 63020252024 53,18260,779 (a) 63020252024 53,18260,779 43,62153,5699,5617,210 53,18260,779 53,18260,779 (b) 5 *2025630 6 16.5%202416.5%2,000,00020242,000,0008.25%20248.25%16.5%202416.5% 12%202412% 25%202425% 202425%202425% 202417%202417% 202410%202410% 21%202421%8.7%20248.7% 20% 20256302024630 7 20256302024630 8 620,441,4642024630618,974,062 20252024630 63020252024 63020252024 * * 9 202563020241231 10 202563020241231 4,6273,579 *202563022,317,0002024123122,987,000 **C R OCDMOSMO 202463060.87.6202563053.2202312®202320246302025630202422.0 202463027.310.8202563038.1 2024630130.850.9202563079.9 202463056.019.0202563037.0 202463058.519.2202563039.3 2025630 202563012527 2025630794.120241231900.12025630 2025630 2025630850.4794.156.32025630190.1142.740.07.4 100%2025630447.4%20241231653.4% 100%202563039.5%2024123136.7% 20256302025630 2025630 2025630 202563041.8 C1C.2.1 C.2.1 C3 2025630 202011202,274.702025630376.61 202011920243222025630 (1)(2)202432220231231553.932024322(3)2025630376.6120261231 RafaelFonseca 2025630 24102025630 25% 2025630 2025630 (www.hkexnews.hk)(www.antengene.com)2025630D220259 2025822 Rafael Fonseca